Postmarketing Study of Empliciti in Korean Patients With Multiple Myeloma (Q62062413)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Postmarketing Study of Empliciti in Korean Patients With Multiple Myeloma |
clinical trial |
Statements
Empliciti (Elotuzumab) Postmarketing Surveillance in Korean Patients With Multiple Myeloma (English)
0 references
31 January 2019
0 references
10 February 2023
0 references
96
0 references
19 year
0 references